Immune-mediated inflammatory disease (IMID) treatment market was valued at $121.0 billion in 2025 and is projected to reach $191.04 billion by 2035, growing at a CAGR of 4.67% during the forecast period (2026–2035). The rising global burden of chronic inflammatory and autoimmune diseases, coupled with increased adoption of biologics and targeted therapies, is significantly driving market expansion. Governments and healthcare systems are increasingly prioritizing early diagnosis and long-term disease management to reduce disability and healthcare costs associated with IMIDs. Advanced biologics and targeted synthetic DMARDs are playing a critical role in improving patient outcomes by offering higher efficacy, reduced disease progression, and personalized treatment approaches.

Glider aircraft market was valued at $580 million in 2025 and is projected to reach $910 million by 2035, growing at a CAGR of 4.6% during the forecast period (2026–2035). The rising emphasis on sustainable and low-emission aviation is emerging as a key macro driver supporting market expansion. Governments and aviation authorities are increasingly promoting eco-friendly flight training and recreational aviation activities, where gliders offer a zero-emission alternative to powered aircraft. With no onboard fuel consumption during flight, gliders align with global decarbonization goals and are gaining traction across pilot training institutions, sports aviation communities, and tourism operators.

Gas analyzer market was valued at $4.05 billion in 2025 and is projected to reach $7.51 billion by 2035, growing at a CAGR of 6.36% during the forecast period (2026–2035). The increasing enforcement of environmental regulations and industrial emission standards is a key factor driving demand for advanced gas analysis solutions across industries. Governments globally are strengthening policies to monitor and control air pollution, greenhouse gas emissions, and workplace safety, thereby accelerating the adoption of gas analyzers in industrial automation applications.

The global fiberglass market was valued at $26.1 billion in 2025 and is projected to reach $47.9 billion by 2035, growing at a CAGR of 6.2% during the forecast period (2026–2035). The market growth is primarily driven by the rapid expansion of the construction and infrastructure sector globally, supported by increasing urbanization and government-led investments in sustainable and energy-efficient building materials. Fiberglass, known for its high strength-to-weight ratio, corrosion resistance, and thermal insulation properties, is widely used in reinforced composites, insulation systems, and structural applications, making it a critical material in modern infrastructure development.

Cytotoxic drugs market was valued at $20.32 billion in 2025 and is projected to reach $36.21 billion by 2035, growing at a CAGR of 5.95% during the forecast period (2026–2035). The increasing global burden of cancer is significantly driving demand for cytotoxic drugs, which remain a cornerstone in chemotherapy-based treatment regimens. Rising incidence rates of solid tumors and hematological malignancies, combined with expanding access to oncology care, are reinforcing the adoption of cytotoxic therapies across both developed and emerging markets. Despite the growing shift toward targeted therapies, cytotoxic drugs continue to play a critical role due to their broad-spectrum efficacy and cost-effectiveness.

Cluster headache market was valued at $0.78 billion in 2025 and is projected to reach $1.45 billion by 2035, expanding at a CAGR of 6.4% during the forecast period (2026–2035). The market growth is primarily driven by the increasing burden of neurological disorders and the rising demand for effective pain management therapies. According to the World Health Organization (WHO), neurological conditions account for nearly 6.3% of the global disease burden, highlighting the need for targeted treatment solutions such as cluster headache therapies.

Cervical cancer treatment market was valued at $4.5 billion in 2025 and is projected to reach $8.6 billion by 2035, growing at a CAGR of 6.8% during the forecast period (2025–2035). Cervical cancer remains one of the most prevalent cancers among women globally, driving the demand for effective treatment solutions. Treatment approaches include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, all of which play a critical role in improving survival rates and patient outcomes.

Antioxidant beverages market was valued at $15.49 billion in 2025 and is projected to reach $31.42 billion by 2035, growing at a CAGR of 7.3% during the forecast period (2026–2035). The rising global focus on preventive healthcare and functional nutrition is significantly driving demand for antioxidant-rich beverages. Increasing consumer awareness regarding oxidative stress, immunity enhancement, and chronic disease prevention is accelerating the adoption of beverages fortified with vitamins, polyphenols, and plant-based antioxidants. This shift toward health-oriented consumption patterns is reinforcing steady growth across both developed and emerging markets.

Anti-hypertensive drugs market was valued at $26.10 billion in 2025 and is projected to reach $38.16 billion by 2035, growing at a CAGR of 3.85% during the forecast period (2026–2035). The increasing global burden of hypertension is a primary driver accelerating demand for anti-hypertensive therapeutics. The rising prevalence of cardiovascular diseases, aging populations, and sedentary lifestyles is significantly contributing to sustained market expansion. According to the . This growing disease burden is intensifying the demand for effective pharmacological interventions, thereby strengthening the adoption of anti-hypertensive drugs across both developed and emerging economies.

Antidepressant Drugs Market is projected to grow from $27.1 billion in 2025 to $43.5 billion by 2035, registering a compound annual growth rate (CAGR) of 4.8% during the forecast period. The increasing global burden of mental health disorders and rising demand for effective pharmacological treatments primarily drive the market expansion.